MolNFT v1 · #146097 · protein

Ctx-M-14 apoenzyme D233N point mutant

6D7I · Beta-lactamase: “Ctx-M-14 apoenzyme D233N point mutant”. X-ray diffraction, 1 pocket (best druggability 0.34). MolNFT v1 #146097 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB: 6D7I
Type: protein
Length: 262 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Beta-lactamase
EC: 3.5.2.6
UniProt: Q9L5C7
Pockets: 1 · best druggability 0.34

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 19% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Beta-lactamase (EC 3.5.2.6)	protein	262	43% helix, 19% strand	Q9L5C7

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	71	0.34	0.76	21	empty

Compared structures

6D7I · CTX-M-14 Apoenzyme D233N Point Mutant · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt Q9L5C7
Elsewhere: RCSB PDB 6D7I · PDBe 6D7I · UniProt Q9L5C7

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.